You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 108 No. 4, April 1982 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Intra-arterial Cisplatin Treatment of Adenoid Cystic Carcinoma

Roy B. Sessions, MD; Daniel E. Lehane, MD; Richard J. H. Smith, MD; R. Nick Bryan, MD, PhD; James Y. Suen, MD

Arch Otolaryngol. 1982;108(4):221-224.


Abstract

• Adenoid cystic carcinoma (ACC) is unique among salivary gland tumors in both its natural history and in its response to nonsurgical treatment methods (ie, radiation and chemotherapy). The chemotherapeutic agent, cisplatin, seems to be unique in its ability to affect ACC. It might be that ACCs of the minor salivary glands are especially vulnerable to the intra-arterial method of administering this drug, because there are accessible feeding vessels to most locations in which these tumors occur. We have treated four patients with advanced ACC with intra-arterial cisplatin. The responses suggest that this method may be a useful adjunct in the management of this tumor both as a preoperative and as a palliative measure.

(Arch Otolaryngol 1982;108:221-224)



Author Affiliations

From the Departments of Otolaryngology (Drs Sessions and Smith), Pharmacology and Medicine (Dr Lehane), and Radiology (Dr Bryan), Baylor College of Medicine, Houston; and the Department of Otolaryngology and Maxillofacial Surgery, University of Arkansas for Medical Sciences, Little Rock (Dr Suen).


Footnotes

Accepted for publication Sept 25, 1981.

Reprint requests to the Department of Otolaryngology, Baylor College of Medicine, 6501 Fannin, Houston, TX 77030 (Dr Sessions).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Neoadjuvant Intracarotid Chemotherapy for Treatment of Advanced Adenocystic Carcinoma of the Lacrimal Gland
Meldrum et al.
Arch Ophthalmol 1998;116:315-321.
ABSTRACT | FULL TEXT  

Intra-arterial Chemotherapy: A Welcome New Idea for the Management of Adenocystic Carcinoma of the Lacrimal Gland
Goldberg
Arch Ophthalmol 1998;116:372-373.
FULL TEXT  

RESIDENTS PAGE: PATHOLOGY
ASKIN and WESTRA
Arch Otolaryngol Head Neck Surg 1995;121:1320-1323.
ABSTRACT  

Malignant Salivary Gland Tumors of the Paranasal Sinuses and Nasal Cavity
Goepfert et al.
Arch Otolaryngol Head Neck Surg 1983;109:662-668.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1982 American Medical Association. All Rights Reserved.